# Epigenomics AG (EPGNF)

> Healthcare · DE · Reports in EUR

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/EPGNF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | N/A | N/A | N/A | € 11.38M | € 2.0K |
| 2023 | € 360.0K | € -4.74M | € -6.06M | € 11.89M | € -8.02M |
| 2022 | € 529.6K | € -13.13M | € -14.62M | € 841.0K | € 10.17M |
| 2021 | € 7.40M | € -2.90M | € -4.99M | € 460.0K | € 22.12M |
| 2020 | € 1.05M | € -14.63M | € -12.01M | € 683.0K | € 3.86M |
| 2019 | € 1.40M | € -21.24M | € -17.01M | € 913.0K | € 9.63M |
| 2018 | € 1.94M | € -16.06M | € -13.23M | € 0 | € 18.61M |
| 2017 | € 2.39M | € -13.14M | € -13.21M | € 6.54M | € 10.58M |
| 2016 | € 5.47M | € -14.53M | € -18.94M | € 0 | € 14.42M |
| 2015 | € 2.74M | € -11.82M | € -10.97M | € 1.07M | € 7.10M |
| 2014 | € 1.99M | € -11.68M | € -10.68M | € 1.93M | € 6.11M |
| 2013 | € 2.09M | € -9.76M | € -8.59M | € 1.93M | € 6.46M |
| 2012 | € 1.38M | € -16.19M | € -14.53M | € 0 | € 4.16M |
| 2011 | € 1.95M | € -21.14M | € -16.62M | € 0 | € 16.19M |
| 2010 | € 2.49M | € -16.01M | € -14.19M | € 9.0K | € 31.30M |
| 2009 | € 6.07M | € -14.58M | € -15.62M | € 37.0K | € 12.08M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 5,690.50 |
| Liabilities / Eq | 5,806.50 |
| Current Ratio | 110.25 |

## Other views

- [Metrics](https://sponda.capital/en/EPGNF.md)
- [Charts](https://sponda.capital/en/EPGNF/charts.md)
- [Compare](https://sponda.capital/en/EPGNF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.